Number
|
Birth weight category [grams]
|
Gestational age [weeks]
|
Gender [m/f]
|
Mutliple [y/n]
|
Gentamicin treatment [y/n]
|
Result of hearing screening
|
---|
1
|
1100-1199
|
28
|
M
|
Y
|
Y
|
Pass
|
2
|
1100-1199
|
28
|
M
|
Y
|
Y
|
Pass
|
3
|
800-899
|
25
|
F
|
N
|
Y
|
Pass
|
4
|
1200-1299
|
29
|
M
|
N
|
N
|
Pass
|
5
|
1200-1299
|
32
|
F
|
N
|
N
|
Pass
|
6
|
1200-1299
|
29
|
F
|
Y
|
Y
|
Pass
|
7
|
800-899
|
29
|
F
|
Y
|
Y
|
Fail
|
8
|
1400-1499
|
32
|
M
|
N
|
Y
|
Pass
|
9
|
1300-1399
|
30
|
M
|
N
|
Y
|
Pass
|
10
|
1400-1499
|
30
|
F
|
Y
|
Y
|
Pass
|
11
|
1300-1399
|
30
|
F
|
Y
|
Y
|
Fail
|
12
|
<400
|
24
|
M
|
N
|
Y
|
Fail
|
- Birth weight and gestational age are given as completed 100 grams/completed weeks, respectively. All aminoglycoside treated infants received gentamicin. Patients 1 and 2, 6 and 7 and patients 10 and 11 were twin pairs. None of the patients was treated with furosemide.